Envista Holdings Corp NVST

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $28.07
Market Cap $4.57B
P/E Ratio 100.25
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑8.3% YoY
$2.72B
3-Yr CAGR: 1.9%
Net Income ↑104.2% YoY
$47.00M
Net Margin: 1.7%
Free Cash Flow ↓-23.9% YoY
$230.40M
FCF Yield: 5.04%
EPS (Diluted) ↑104.3% YoY
$0.28
Basic: $0.28
Return on Equity Efficiency
1.5%
ROA: 0.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NVST)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $2,810.9M $1,621.2M $301.1M $2.35 $359.1M $310.2M
FY 2018 $2,844.5M +1.2% $1,601.8M $230.7M -23.4% $1.80 -23.4% $400.1M $327.9M +5.7%
FY 2019 $2,751.6M -3.3% $1,513.1M $217.6M -5.7% $1.60 -11.1% $397.5M $319.7M -2.5%
FY 2020 $2,282.0M -17.1% $1,158.1M $33.3M -84.7% $0.20 -87.5% $283.9M $236.2M -26.1%
FY 2021 $2,508.9M +9.9% $1,426.5M $340.5M +922.5% $1.92 +860.0% $361.6M $306.9M +29.9%
FY 2022 $2,569.1M +2.4% $1,474.8M $243.1M -28.6% $1.37 -28.6% $182.7M $107.0M -65.1%
FY 2023 $2,566.5M -0.1% $1,440.5M $-100.2M -141.2% $-0.60 -143.8% $275.7M $217.5M +103.3%
FY 2024 $2,510.6M -2.2% $1,372.7M $-1,118.6M -1,016.4% $-6.50 -983.3% $336.5M $302.7M +39.2%
FY 2025 $2,719.5M +8.3% $1,486.7M $47.0M +104.2% $0.28 +104.3% $275.7M $230.4M -23.9%
$

Valuation

Market Price $28.07
Market Cap $4.57B
Enterprise Value $4.95B
P/E Ratio 100.25
P/B Ratio 1.47
FCF Yield 5.04%
Dividend Yield N/A
Shares Outstanding 162,727,900
%

Profitability & Margins

Gross Margin 54.67%
Operating Margin 7.95%
Net Margin 1.73%
Return on Equity (ROE) 1.51%
Return on Assets (ROA) 0.83%
Asset Turnover 0.48x
Revenue 3-Yr CAGR 1.91%
🛡️

Financial Health & Liquidity

Current Ratio 0.11
Cash Ratio 1.42
Debt / Equity 0.514
Debt / Assets 0.281
Cash & Equivalents $1.21B
Total Debt $1.60B
Book Value / Share $19.09
💧

Cash Flow Efficiency

Operating Cash Flow $275.70M
Capital Expenditures (CapEx) $45.30M
Free Cash Flow $230.40M
OCF / Revenue 10.14%
FCF / Revenue 8.47%
FCF 3-Yr CAGR 29.13%
🏷️

Per Share Metrics

EPS (Diluted) $0.28
EPS (Basic) $0.28
Dividends / Share N/A
Book Value / Share $19.09
EPS YoY Growth 104.31%
🏛️

Balance Sheet (FY 2025)

Total Assets $5.68B
Total Liabilities $5.68B
Stockholders' Equity $3.11B
Current Assets $97.20M
Current Liabilities $852.60M